Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 30, 2014 07:00 ET | Source: Stemline Therapeutics, Inc.

Stemline Therapeutics to Present at the Deutsche Bank 39th Annual Health Care Conference

NEW YORK, April 30, 2014 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) announced today that Ivan Bergstein, M.D., Stemline's CEO, will present at the Deutsche Bank 39th Annual Health...
April 08, 2014 07:00 ET | Source: Stemline Therapeutics, Inc.

Stemline Therapeutics Announces FDA Acceptance of IND for SL-701, a Synthetic Multi-Peptide Vaccine Targeting Glioma Brain Tumors

NEW YORK, April 8, 2014 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) announced today that the U.S. Food and Drug Administration (FDA) has accepted the company's Investigational New...
April 07, 2014 07:00 ET | Source: Stemline Therapeutics, Inc.

Stemline Therapeutics to Present at the 13th Annual Needham Healthcare Conference

NEW YORK, April 7, 2014 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) announced today that Ivan Bergstein, M.D., Stemline's CEO, will present at the 13th Annual Needham Healthcare...
April 01, 2014 07:00 ET | Source: Stemline Therapeutics, Inc.

Stemline Therapeutics Announces Presentation of SL-501 Preclinical Efficacy Data in TKI-Resistant CML at the Annual Meeting of the American Association of Cancer Research (AACR)

NEW YORK, April 1, 2014 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) announced today that data demonstrating SL-501 inhibits the growth of tyrosine kinase inhibitor (TKI) resistant...
March 06, 2014 07:00 ET | Source: Stemline Therapeutics, Inc.

Stemline Therapeutics to Present at the 26th Annual ROTH Conference

NEW YORK, March 6, 2014 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) announced today that Ivan Bergstein, M.D., Stemline's CEO, will present at the 26th Annual ROTH Conference on...
February 26, 2014 07:00 ET | Source: Stemline Therapeutics, Inc.

Stemline Therapeutics to Present at Cowen and Company Health Care Conference

NEW YORK, Feb. 26, 2014 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) announced today that Ivan Bergstein, M.D., Stemline's CEO, will present at the Cowen and Company 34th Annual...
February 20, 2014 07:00 ET | Source: Stemline Therapeutics, Inc.

Stemline Therapeutics to Present at Citi 2014 Global Healthcare and RBC Capital Markets Conferences

NEW YORK, Feb. 20, 2014 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) announced today that it will present at the Citi 2014 Global Healthcare and RBC Capital Markets Global Healthcare...
February 06, 2014 07:00 ET | Source: Stemline Therapeutics, Inc.

Stemline Therapeutics to Present at the Leerink Global Healthcare Conference

NEW YORK, Feb. 6, 2014 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) announced today that Ivan Bergstein, M.D., Stemline's CEO, will present at the Leerink Global Healthcare Conference...
February 04, 2014 07:00 ET | Source: Stemline Therapeutics, Inc.

Stemline Therapeutics to Present at the 16th Annual BIO CEO & Investor Conference

NEW YORK, Feb. 4, 2014 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) announced today that Ivan Bergstein, M.D., Stemline's CEO, will present at the 16th Annual Biotechnology Industry...
January 07, 2014 07:00 ET | Source: Stemline Therapeutics, Inc.

Stemline Therapeutics to Present at the 32nd Annual J.P. Morgan Healthcare Conference

NEW YORK, Jan. 7, 2014 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) announced today that Ivan Bergstein, M.D., Stemline's CEO, will present at the 32nd Annual J.P. Morgan Healthcare...